(Q44364462)

2 December 2017

title

Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods (English)

1 reference

2 December 2017

1 reference

Adriaan A Lammertsma

6

0 references

author name string

Nanda C Krak

1

1 reference

2 December 2017

Jacobus J M van der Hoeven

2

1 reference

2 December 2017

Otto S Hoekstra

3

1 reference

2 December 2017

Jos W R Twisk

4

1 reference

2 December 2017

Elsken van der Wall

5

1 reference

2 December 2017

publication date

15 March 2003

1 reference

2 December 2017

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

2 December 2017

volume

30

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

674-681

1 reference

On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies

2 December 2017

cites work

1 reference

12 December 2020

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.

1 reference

12 December 2020

Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

1 reference

12 December 2020

Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Anatomy of SUV. Standardized uptake value

1 reference

12 December 2020

Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images

1 reference

12 December 2020

Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer

1 reference

12 December 2020

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas

1 reference

12 December 2020

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

12 December 2020

Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours

1 reference

12 December 2020

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

12 December 2020

Breast imaging with fluorine-18-FDG PET: quantitative image analysis

1 reference

12 December 2020

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

12 December 2020

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

12 December 2020

Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.

1 reference

12 December 2020

Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer

1 reference

12 December 2020

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Comparison of simplified quantitative analyses of FDG uptake

1 reference

12 December 2020

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

12 December 2020

Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction.

1 reference

12 December 2020

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

12 December 2020

Noninvasive determination of local cerebral metabolic rate of glucose in man.

1 reference

12 December 2020

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study

1 reference

12 December 2020

Accelerated image reconstruction using ordered subsets of projection data

1 reference

12 December 2020

A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography

1 reference

12 December 2020

Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography

1 reference

12 December 2020

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose

1 reference

12 December 2020

Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers

1 reference

12 December 2020

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

1 reference

12 December 2020

The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?

1 reference

12 December 2020

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

1 reference

12 December 2020

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

1 reference

12 December 2020

Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction

1 reference

12 December 2020

Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans

1 reference

12 December 2020

The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

1 reference

12 December 2020

SUV: standard uptake or silly useless value?

1 reference

12 December 2020

Simplified measurement of deoxyglucose utilization rate

1 reference

12 December 2020

Diagnostic value of positron emission tomography for detecting breast cancer

1 reference

12 December 2020

FDG-PET in Breast Cancer A Different View of its Clinical Usefulness

1 reference

12 December 2020

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue

1 reference

12 December 2020

Quantification of serial tumor glucose metabolism

1 reference

12 December 2020

10.1007/S00259-003-1127-Z

Identifiers

DOI

1 reference

2 December 2017

1 reference